m-RESIST: The vision which became a reality!
The m-RESIST Final Review will be held on February 20, 2018, at the EC premises in Brussels, to validate project results and achievements. This three-year project (2015- 2017), of more than 3 million euros, developed an innovative disease management system focused on the needs of patients with Treatment-Resistant Schizophrenia, studying new therapeutic protocols and disease management methods based on mobile technologies.